DENSOMERE

Live / Applied — Fifth extension granted (statement of use) (as of 18 Nov 2025)

What this means for you

Not registered yet, but its 22 Sept 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97040402
Mark type
Stylized text
Filed
22 Sept 2021
Published for opposition
21 Mar 2023
Attorney of record
Kathleen A. Costigan

Goods and services

  • Class 005 — Pharmaceuticals: Drug delivery agents in hypercompressed solid dosage form for implantation under the skin or within the tissue of a bodily organ or within a bodily structure, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in hypercompressed solid dosage form for injection under the skin or within the tissue of a bodily organ or within a bodily structure, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in hypercompressed solid dosage form for inhalation or taken orally or placed on the skin for local absorption through the skin, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in a hypercompressed dosage form in a liquid for implantation under the skin or within the tissue of a bodily organ or within a bodily structure, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in a hypercompressed dosage form in a liquid for injection under the skin or within the tissue of a bodily organ or within a bodily structure, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in a hypercompressed dosage form in a liquid for inhalation or taken orally or placed on the skin for local absorption through the skin, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals

Owner

Prosecution history

  • 19 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 18 Nov 2025 — SOU EXTENSION 5 GRANTED
  • 16 Nov 2025 — SOU EXTENSION 5 FILED
  • 17 Nov 2025 — SOU TEAS EXTENSION RECEIVED
  • 17 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 17 May 2025 — SOU EXTENSION 4 GRANTED
  • 16 May 2025 — SOU EXTENSION 4 FILED
  • 16 May 2025 — SOU TEAS EXTENSION RECEIVED
  • 12 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 11 Feb 2025 — SOU EXTENSION 3 GRANTED
  • 18 Nov 2024 — SOU EXTENSION 3 FILED
  • 11 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 18 Nov 2024 — SOU TEAS EXTENSION RECEIVED
  • 17 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 16 May 2024 — SOU EXTENSION 2 GRANTED

View this trademark record on Marksy